Genflow Biosciences plc

OTCPK:GENF.F Stock Report

Market Cap: US$8.1m

Genflow Biosciences Balance Sheet Health

Financial Health criteria checks 6/6

Genflow Biosciences has a total shareholder equity of £858.3K and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £1.4M and £492.8K respectively.

Key information

0%

Debt to equity ratio

UK£0

Debt

Interest coverage ration/a
CashUK£1.14m
EquityUK£858.35k
Total liabilitiesUK£492.76k
Total assetsUK£1.35m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: GENF.F's short term assets (£1.3M) exceed its short term liabilities (£492.8K).

Long Term Liabilities: GENF.F has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: GENF.F is debt free.

Reducing Debt: GENF.F has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: GENF.F has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: GENF.F has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 19.5% each year.


Discover healthy companies